Charles A Rowland Jr insider trades: Viking Therapeutics (VKTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
and 4 more companies
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 27, 2025 | VKTX | ↓ Sell | 60,000 | $35.57 | $2.1M | Direct | Oct 28, 2025 (1d) |
| Dec 4, 2023 | GBIO | ↑ Buy | 342,960 | $1.39 | $478K | Direct | Dec 5, 2023 (1d) |
| May 16, 2023 | VKTX | ↓ Sell | 40,000 | $25.00 | $1.0M | Direct | May 18, 2023 (2d) |
| Sep 19, 2022 | GBIO | ↑ Buy | 15,750 | $5.26 | $83K | Direct | Sep 20, 2022 (1d) |
| Sep 16, 2022 | GBIO | ↑ Buy | 50,628 | $5.46 | $276K | Direct | Sep 19, 2022 (3d) |
| Sep 14, 2022 | GBIO | ↑ Buy | 24,384 | $5.22 | $127K | Direct | Sep 15, 2022 (1d) |
| Aug 1, 2022 | NBRV | ↓ Sell | 8,496 | $0.17 | $1K | Direct | Aug 3, 2022 (2d) |
| Aug 2, 2021 | NBRV | ↓ Sell | 777 | $1.20 | $932 | Direct | Aug 4, 2021 (2d) |
| Jan 11, 2021 | GBIO | ↑ Buy | 20,408 | $24.50 | $500K | Direct | Jan 13, 2021 (2d) |
| Dec 17, 2020 | BPMC | ↓ Sell | 10,909 | $117.82 | $1.3M | Direct | Dec 18, 2020 (1d) |
| Nov 3, 2020 | BPMC | ↓ Sell | 10,000 | $98.90 | $989K | Direct | Nov 4, 2020 (1d) |
| Jun 16, 2020 | GBIO | ↑ Buy | 30,000 | $19.00 | $570K | Direct | Jun 18, 2020 (2d) |
| Jun 20, 2019 | BPMC | ↓ Sell | 11,818 | $95.15 | $1.1M | Direct | Jun 24, 2019 (4d) |
| Dec 24, 2018 | NBRV | ↑ Buy | 53,000 | $1.31 | $69K | Direct | Dec 27, 2018 (3d) |
| May 29, 2018 | VKTX | ↑ Buy | 30,000 | $5.16 | $155K | Direct | May 31, 2018 (2d) |
| Mar 1, 2012 | VPHM | ↓ Sell | 82,750 | $32.12 | $2.7M | Direct | Mar 5, 2012 (4d) |
| Mar 14, 2011 | VPHM | ↓ Sell | 35,000 | $18.57 | $650K | Direct | Mar 15, 2011 (1d) |
| Feb 26, 2009 | VPHM | ↑ Buy | 16,000 | $4.78 | $77K | Direct | Feb 27, 2009 (1d) |
| Nov 3, 2008 | VPHM | ↑ Buy | 8,000 | $12.77 | $102K | Direct | Nov 5, 2008 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VKTX insiders
Open-market trades in the last 12 months
About Charles A Rowland Jr's insider trades
Charles A Rowland Jr is an insider at Viking Therapeutics (VKTX). Since Nov 3, 2008, Charles has reported 10 open-market purchases worth $2.4M and 9 sales worth $9.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (55 filings), option exercises (13 filings), shares returned to the company (5 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VKTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.